Thus, the cell of origin may not be stemness-dependent (although stem cells are much more efficient in tumor formation) but rather dependent on a serial event (e.g., initial Msh2 deletion followed by accumulation of other mutations or initial Apc deletion followed by inflammation (86)). The gene discussed is MSH2; the disease is neoplasm.